本頁面由Tiger Trade Technology Pte. Ltd.提供服務

眾巢醫學

1.62
+0.03502.22%
成交量:1.35萬
成交額:2.18萬
市值:716.54萬
市盈率:0.00
高:1.64
開:1.58
低:1.58
收:1.58
52周最高:46.56
52周最低:0.1428
股本:443.68萬
流通股本:322.94萬
量比:0.85
換手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-343.3536
每股收益(LYR):-114.7000
淨資產收益率:-24.88%
總資產收益率:-15.47%
市淨率:0.38
市盈率(LYR):-0.01

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/26

SEC問詢函

Form CORRESP - Correspondence
2026/05/26

SEC問詢函

Form CORRESP - Correspondence
2026/05/22

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/05/07

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2026/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/15

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/21

SEC問詢函

Form CORRESP - Correspondence
2025/06/07

SEC問詢函

Form CORRESP - Correspondence
2025/05/20

SEC問詢函

Form CORRESP - Correspondence
2025/05/07

SEC問詢函

Form CORRESP - Correspondence
2025/04/25

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

SEC問詢函

Form CORRESP - Correspondence
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership